Pefabloc® FG, Inhibitor for Fibrinogen
Description:Pefabloc
® FG binds with a high affinity to fibrinogen, inhibits fibrin polymerization, modifies the mechanical properties of fibrin clots and can dissociate non-stabilized fibrin gels.
Application:Pefabloc
® FG is added to fibrinogen containing reaction mixtures to inhibit disturbing fibrin-related turbidity, gel formation and fibrin deposition in diagnostic and preparative procedures (e. g. measurement of thrombin generation in plasma). Pefabloc
® FG is also used to inhibit fibrin formation during purification and processing of clotting factors and other plasma proteins.
Recommended Pefabloc® FG concentrations:
Application: |
Concentration: |
Gelation prevention: |
|
des-AB-fibrin |
0.5-2.3 mM |
des-A-fibrin |
2.3 mM |
human plasma, HC-II test |
0.5 mg/ml |
bov. fibrinogen 0.2% / thrombin 0.5 U/ml |
1.5 mg/ml |
|
|
Clot liquefaction: |
|
des-AB-fibrin |
15.0 mM |
des-A-fibrin |
1.0 mM |
Formula: H-Gly-Pro-Arg-Pro-OH · AcOH
MW: 485.5
Solubility: readily soluble in water
Storage:
May be used by the expiry date given on the label when stored unopened, protected from moisture, in the dark, 2-8°C. Avoid contamination of the reagents by micro-organisms. Shipment of product does not require cooling during the time of transportation.
Category: Research use only
Type: Inhibitor
Product Availability: Germany, Israel and Egypt
Manufacturer: DSM Nutritional Products Ltd. Branch Pentapharm, Switzerland
For more information please click .pdf icon below.
Pefabloc FG
Inhibitor for Fibrinogen
Artikelnr.: 809901
Einheit: 1 g
Code: 099-01
Hersteller: Pentapharm AG
References:
- Furlan M, Rupp C, Beck E A, Svendsen L.
Effect of calcium and synthetic peptides on fibrin polymerization. Thromb Haemost 1982; 47: 118-21.
- Prasa D, Svendsen L, Stürzebecher J.
The ability of thrombin inhibitors to reduce the thrombin activity generated in plasma on extrinsic and intrinsic Activation. Thromb Haemost 1997; 77: 498-503.